gene expression | Acta Medica Marisiensis

The impact of microRNA-596 on oral cancer: Insights into tumor biology and treatment strategies

Shereen Farhana P¹, Ameya K P², Ashikha Shirin Usman P P², Durairaj Sekar²

1. Department of Prosthodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai, India
2. RNA Biology Lab, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai, India

DOI: 10.2478/amma-2025-0007

Objectives: Despite advancements in treatment, oral squamous cell carcinoma (OSCC) remains a major global health issue with stagnant survival rates. MicroRNAs (miRNAs), particularly miR-596, play critical roles in cancer, acting as both oncogenes and tumor suppressors. This study aims to clarify miR-596’s function in OSCC and assess its potential as a therapeutic target or diagnostic biomarker.
Methods: A thorough bioinformatics analysis utilising information from The Cancer Genome Atlas (TCGA) led to the selection of miR-596 for investigation. After extracting its sequence from miRBase, RNAfold was used to evaluate the secondary structure’s functional characteristics. MiRNA expression levels were measured by quantitative reverse transcription PCR (qRT-PCR) on a total of 30 tissue samples, including OSCC and healthy controls. With TargetScan, the miR-596 gene targets were predicted.
Results: miR-596 is significantly downregulated in OSCC tissues compared to healthy controls. TargetScan analysis indicates that miR-596 regulates key genes involved in cell proliferation, metastasis, and apoptosis, suggesting its crucial role in these pathways. Additionally, the predicted secondary structure of miR-596 indicates high stability.
Conclusion: Based on its activity as a tumor suppressor, the study suggests that miR-596 may be an important factor in the development of OSCC. Its potential use as a therapeutic target or diagnostic biomarker is highlighted by the downregulation of miR-596 in OSCC. Validating these results and investigating the therapeutic applications of miR-596 in OSCC treatment require more investigation.

Identification and expression of microRNA-34a-3p and its target Rapamycin-insensitive companion of mTOR (RICTOR) in polycystic ovarian syndrome in South Indian population

Manya Saravanan¹, Ameya K P², Ashikha Shirin Usman P P², Durairaj Sekar²

1. Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai, India
2. RNA Biology Lab, Saveetha Dental College and Hospital, Saveetha Institute of Medical And Technical Science (SIMATS), Saveetha University, Chennai, India

DOI: 10.2478/amma-2024-0025

Objectives: Polycystic Ovarian Syndrome (PCOS) is a complex condition affecting 4% to 26% of the world-wide population and is characterized by enlarged ovaries and cysts. These cysts are actually immature ovarian follicles that have failed to mature and release an egg, which is a process known as anovulation. This study aims to explore the potential of miRNA as therapeutic and diagnostic biomarkers for PCOS, focusing on the identification and expression analysis of novel candidates like miR-34a-3p and its target Rapamycin-insensitive companion of mTOR (RICTOR). The objective is to enhance our understanding of the molecular mechanisms associated with PCOS, particularly the roles of miRNAs in its pathogenesis. In future, we plan to test miR-34a-3p mimics/inhibitors and RICTOR downregulation to improve insulin sensitivity and ovarian function. We will also explore combined therapies and conduct trials to assess their efficacy and safety in PCOS patients, aiming to develop practical treatments for PCOS.
Methods: National Centre for Biotechnology Information (NCBI) database, TargetScan, and miRbase were explored to identify the novel miRNA candidates, resulting in the discovery of miR-34a-3p. Secondary structure was constructed using RNA Fold, and Ct and melt curve analysis assessed its statistical expression levels. Additionally, similar research was conducted to analyze the expression levels of RICTOR, a target of miR-34a-3p.
Result: The secondary structure showed miR-34a-3p has a minimum free energy of -47.20 kcal. Additionally shows dysregulation in both miR-34a-3p and RICTOR in individuals with PCOS. Furthermore, overexpression of RICTOR and decrease in miR-34a-3p levels suggest their possible role in the pathogenesis of PCOS.
Conclusion: In PCOS, miR-34a-3p is downregulated, and there’s an inverse relationship between miR-34a-3p and RICTOR levels. qRT-PCR results showed high RICTOR expression in PCOS patients. RICTOR plays a crucial role in the mTOR pathway, affecting insulin signaling, metabolism, and cellular growth, which are all implicated in PCOS.